Next Article in Journal
Aged Lymphatic Vessels and Mast Cells in Perilymphatic Tissues
Previous Article in Journal
Chemical Profile and Antioxidant, Anti-Inflammatory, Antimutagenic and Antimicrobial Activities of Geopropolis from the Stingless Bee Melipona orbignyi
Previous Article in Special Issue
Essential Roles of E3 Ubiquitin Ligases in p53 Regulation
Article Menu
Issue 5 (May) cover image

Export Article

Open AccessReview
Int. J. Mol. Sci. 2017, 18(5), 961; doi:10.3390/ijms18050961

Mutant p53 Protein and the Hippo Transducers YAP and TAZ: A Critical Oncogenic Node in Human Cancers

Molecular Chemoprevention and Oncogenomic and Epigenetic Units, Italian National Cancer Institute “Regina Elena”, 00144 Rome, Italy
*
Author to whom correspondence should be addressed.
Academic Editor: Tomoo Iwakuma
Received: 2 March 2017 / Revised: 11 April 2017 / Accepted: 24 April 2017 / Published: 3 May 2017
(This article belongs to the Special Issue Emerging Non-Canonical Functions and Regulation of p53)
View Full-Text   |   Download PDF [933 KB, uploaded 3 May 2017]   |  

Abstract

p53 protein is a well-known tumor suppressor factor that regulates cellular homeostasis. As it has several and key functions exerted, p53 is known as “the guardian of the genome” and either loss of function or gain of function mutations in the TP53 coding protein sequence are involved in cancer onset and progression. The Hippo pathway is a key regulator of developmental and regenerative physiological processes but if deregulated can induce cell transformation and cancer progression. The p53 and Hippo pathways exert a plethora of fine-tuned functions that can apparently be in contrast with each other. In this review, we propose that the p53 status can affect the Hippo pathway function by switching its outputs from tumor suppressor to oncogenic activities. In detail, we discuss: (a) the oncogenic role of the protein complex mutant p53/YAP; (b) TAZ oncogenic activation mediated by mutant p53; (c) the therapeutic potential of targeting mutant p53 to impair YAP and TAZ oncogenic functions in human cancers. View Full-Text
Keywords: mutant p53; Hippo pathway; YAP; TAZ; tumor suppressor; oncogene; migration; proliferation; apoptosis; senescence mutant p53; Hippo pathway; YAP; TAZ; tumor suppressor; oncogene; migration; proliferation; apoptosis; senescence
Figures

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Ferraiuolo, M.; Verduci, L.; Blandino, G.; Strano, S. Mutant p53 Protein and the Hippo Transducers YAP and TAZ: A Critical Oncogenic Node in Human Cancers. Int. J. Mol. Sci. 2017, 18, 961.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top